Search

Search Results
Results 7551 - 7560 of 8337 for Skin Cancer
  • News - 22 Dec 2009
    LEO Pharma today announced positive results for the company’s two Phase III actinic (solar) keratosis (AK) clinical trials using PEP005 (ingenol mebutate) Gel for the treatment of lesions on head...
  • News - 5 Feb 2008
    Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation,...
  • Drug - 12 May 2025
    Consumer Medicine Information (CMI) about Allopurinol Alphapharm intended for persons living in Australia.
  • Drug - 24 Apr 2025
    Consumer Medicine Information (CMI) about Risperdal Tablets and Solution intended for persons living in Australia.
  • Drug - 24 Apr 2025
    Consumer Medicine Information (CMI) about Dexamethasone Viatris intended for persons living in Australia.
  • Drug - 17 Apr 2025
    Consumer Medicine Information (CMI) about Minidiab intended for persons living in Australia.
  • Drug - 16 Apr 2025
    Consumer Medicine Information (CMI) about Noxicid Caps Heartburn Relief intended for persons living in Australia.
  • Health - 16 Apr 2025
    The distinction between biological and chronological age is vital for risk assessment and interventions aimed at enhancing longevity and quality of life.
  • Drug - 15 Apr 2025
    Consumer Medicine Information (CMI) about Stelara intended for persons living in Australia.
  • Drug - 10 Apr 2025
    Consumer Medicine Information (CMI) about Clopixol intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.